Welcome to Medications.com
Gilead Fights Deadly Diseases - CNNMoney.com
Despite competition from GlaxoSmithKline's (NYSE:GSK) GSK Trizivir and Abbott Laboratories (NYSE:ABT) ' ABT Lopinavir, Gilead's HIV treatments continued to ...
http://money.cnn.com/news/newsfee... |
Posted: Fri Jan 18 20:11:30 -0500 2008
Trizivir RSS Feed
© 2002-2007, Skylabs Inc. |
About Us |
Disclaimer/Terms of Use |
Advertise |
Contact Us |
Site Map |
Developed by:
W3matter.com |
Sleep Apnea
